Initial Validation of the Mid-Atlantic Mental Illness Research, Education, and Clinical Center Assessment of Traumatic Brain Injury

Rowland, Jared A.; Martindale, Sarah L.; Shura, Robert D.; Miskey, Holly M.; Bateman, James R.; Epstein, Erica L.; Stern, Mark J.; Hurley, Robin A.; Taber, Katherine H.

doi:10.1089/neu.2019.6972

Cited by 17 publications

(13 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Exclusion criteria (e.g., neurologic disorder, severe mental illness) were initially evaluated within the medical record and subsequently during the telephone screen. TBI exclusion criteria were evaluated using the Mid-Atlantic MIRECC Assessment of TBI (MMA-TBI; Rowland et al, 2020). Psychiatric exclusion criteria were fully evaluated using the Structured Clinical Interview for DSM-IV Disorders (SCID-IV; First et al, 1996) as part of the study visit.…”

Section: Methodsmentioning

confidence: 99%

Performance validity and symptom validity tests: Are they measuring different constructs?

Ord¹,

Shura²,

Sansone³

et al. 2021

Neuropsychology

Self Cite

View full text Add to dashboard Cite

Objective: To evaluate the relationships among performance validity, symptom validity, symptom self-report, and objective cognitive testing. Method: Combat Veterans (N = 338) completed a neurocognitive assessment battery and several self-report symptom measures assessing depression, posttraumatic stress disorder (PTSD) symptoms, sleep quality, pain interference, and neurobehavioral complaints. All participants also completed two performance validity tests (PVTs) and one stand-alone symptom validity test (SVT) along with two embedded SVTs. Results: Results of an exploratory factor analysis revealed a three-factor solution: performance validity, cognitive performance, and symptom report (SVTs loaded on the third factor). Results of t tests demonstrated that participants who failed PVTs displayed significantly more severe symptoms and significantly worse performance on most measures of neurocognitive functioning compared to those who passed. Participants who failed a standalone SVT also reported significantly more severe symptomatology on all symptom report measures, but the pattern of cognitive performance differed based on the selected SVT cutoff. Multiple linear regressions revealed Key Points Question: Are performance validity tests (PVTs) and symptom validity tests (SVT) measuring different constructs, and are they differentially related to cognition and clinical symptoms? Findings: Symptom validity and performance validity are distinct but related constructs, and both are associated with cognitive performance and with symptom self-report. Importance: A comprehensive neuropsychological assessment battery should include both SVT and PVTs because they provide unique information about an examinee's performance. Next Steps: Further evaluation of specific symptom validity measures is necessary to assess distinct differences between symptom validity and symptom selfreport, as well as to determine whether higher cutoffs would be more appropriate for various populations, such as combat-exposed Veterans.

show abstract

Section: Methodsmentioning

confidence: 99%

Performance validity and symptom validity tests: Are they measuring different constructs?

Ord¹,

Shura²,

Sansone³

et al. 2021

Neuropsychology

Self Cite

View full text Add to dashboard Cite

show abstract

“…The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) determined current PTSD diagnosis and severity. The Mid-Atlantic MIRECC Assessment of Traumatic Brain Injury (MMA-TBI; Rowland et al, 2020) was used to determine history of deployment TBI. The MMA-TBI is a comprehensive lifetime assessment of TBI that evaluates TBI criteria and severity according to the Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Concussion/mild Traumatic Brain Injury (Management of Concussion/mTBI Working Group, 2009Group, , 2016.…”

Section: Methodsmentioning

confidence: 99%

Pain interference and quality of life in combat veterans: Examining the roles of posttraumatic stress disorder, traumatic brain injury, and sleep quality.

Ord

Lad

Shura

et al. 2021

Rehabilitation Psychology

Self Cite

View full text Add to dashboard Cite

Objective: The goal of this study was to examine the associations among posttraumatic stress disorder (PTSD), traumatic brain injury (TBI), sleep quality, pain interference, and quality of life in combat veterans. Method: Veterans (N ϭ 289, 86.51% male) completed the Mid-Atlantic MIRECC Assessment of Traumatic Brain Injury, the Clinician-Administered PTSD Scale for DSM-5, and measures of sleep quality, pain interference, and quality of life. Results: Hierarchical linear regressions evaluated associations between PTSD severity, deployment TBI severity, sleep quality, and the outcomes of pain interference and quality of life after adjusting for demographic variables and the number of nondeployment TBIs. PTSD severity, B ϭ 0.15, SE B ϭ 0.04, deployment TBI severity, B ϭ 3.98, SE B ϭ 1.01, and sleep quality, B ϭ 0.74, SE B ϭ 0.13, were significantly associated with pain interference, p Ͻ .001. PTSD severity, B ϭ Ϫ0.57, SE B ϭ 0.07, and pain interference, B ϭ Ϫ0.45, SE B ϭ 0.11, were significantly, independently associated with quality of life, p Ͻ .001. However, pain interference, B ϭ Ϫ0.24, SE B ϭ 0.11, was no longer significantly associated with quality of life when sleep quality, B ϭ Ϫ1.56, SE B ϭ 0.25, was included in the model. There was no significant association between deployment TBI severity and quality of life. Interactions among the studied variables were not significant for either of the outcome variables. Conclusions: PTSD symptom severity, deployment TBI history, and sleep quality may be important to consider in treatment planning for veterans experiencing pain-related functional interference. For veterans with numerous conditions comorbid with pain, treatment plans may include interventions targeting sleep and PTSD to maximize quality of life improvements.

show abstract

“…The Mid-Atlantic MIRECC Assessment of Traumatic Brain Injury (MMA-TBI; Rowland et al, 2020) is a comprehensive lifetime assessment of TBI that evaluates TBI criteria and severity according to the VA/ DoD Clinical Practice Guideline for the Management of Concussion/Mild Traumatic Brain Injury (Management of Concussion/mTBI Working Group, 2009). All possible head-injury events across the life span are queried, including how and when the injury occurred, as well as characteristic information such as loss of consciousness, posttraumatic amnesia, and alteration of consciousness.…”

Section: Diagnostic Interviewsmentioning

confidence: 99%

Differential effects of deployment and nondeployment mild TBI on neuropsychological outcomes.

Martindale¹,

Ord²,

Lad³

et al. 2021

Rehabilitation Psychology

Self Cite

View full text Add to dashboard Cite

Objective: Mild traumatic brain injury (TBI) that occurs in a deployment environment is characteristically different from mild TBI that occurs outside of deployment. This study evaluated differential and interaction effects of deployment and nondeployment mild TBI on cognitive and behavioral health outcomes. Research Method: Combat veterans (N ϭ 293) who passed performance-validity measures completed the Mid-Atlantic MIRECC Assessment of TBI (MMA-TBI), Clinician-Administered Posttraumatic Stress Disorder (PTSD) Scale (CAPS-5), a neuropsychological assessment battery, and self-report questionnaires. A 2 ϫ 2 ϫ 2 analysis of variance (ANOVA) was conducted to evaluate the main and interaction effects across mild TBI groups and PTSD diagnosis. Results: Deployment TBI was associated with poorer outcomes on several cognitive tests: Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV); Working Memory Index (WMI; p ϭ .018); Trail Making Test A (TMT-A; p Ͻ .001); and Trail Making Test B (TMT-B; p ϭ .002). Deployment TBI and PTSD were also associated with increased PTSD, depressive, and neurobehavioral symptoms; pain interference; and poorer sleep quality. Nondeployment TBI had no effect on cognitive performance and was associated only with poorer sleep quality. PTSD had the strongest associations with symptom measures and deployment TBI with cognitive outcomes. There were no significant interaction effects after adjusting for multiple comparisons. Conclusions: Remote outcomes associated with mild deployment TBI are different from those associated with nondeployment mild TBI and are robust beyond PTSD. This suggests that the environment surrounding a TBI event influences cognitive and symptom sequelae. Veterans who experience mild TBI during deployment may report changes in cognition, but most will continue to function within the expected range. Impact and ImplicationsMild deployment traumatic brain injury (TBI) was associated with lower performance on measures of attention and processing speed. Veterans who experience mild TBI during deployment may be more likely to report changes in cognition to providers. Although most will function in an expected range, implementation of skill building, compensatory strategies, and patient education about recovery from mild TBI may be beneficial in supporting recovery.

show abstract

Initial Validation of the Mid-Atlantic Mental Illness Research, Education, and Clinical Center Assessment of Traumatic Brain Injury

Cited by 17 publications

References 8 publications

Performance validity and symptom validity tests: Are they measuring different constructs?

Performance validity and symptom validity tests: Are they measuring different constructs?

Pain interference and quality of life in combat veterans: Examining the roles of posttraumatic stress disorder, traumatic brain injury, and sleep quality.

Differential effects of deployment and nondeployment mild TBI on neuropsychological outcomes.

Contact Info

Product

Resources

About